KNOLL'S ISOPTIN SR CLEARS FDA WITH FULL NDA; THREE YEARS EXCLUSIVITY FOR DOSAGE AND HYPERTENSIVE INDICATION POSSIBLE; SEARLE'S CALAN-SR ALSO COVERED